LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 89.57 | 84.90 | 3741 | 7494 | 0.4992 | 0.7962 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 89.57 | 84.90 | 4445 | 7494 | 0.5931 | 0.8447 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 89.57 | 84.90 | 4513 | 7494 | 0.6022 | 0.8491 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 91.27 | 84.90 | 3820 | 7420 | 0.5148 | 0.8044 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 91.27 | 84.90 | 3847 | 7420 | 0.5185 | 0.8063 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 91.27 | 84.90 | 4638 | 7420 | 0.6251 | 0.8595 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 91.27 | 84.90 | 4682 | 7420 | 0.6310 | 0.8622 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 92.98 | 84.90 | 3933 | 7257 | 0.5419 | 0.8179 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 92.98 | 84.90 | 3954 | 7257 | 0.5448 | 0.8194 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 92.98 | 84.90 | 4789 | 7257 | 0.6599 | 0.8746 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 92.98 | 84.90 | 4828 | 7257 | 0.6652 | 0.8769 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 94.68 | 84.90 | 4006 | 7000 | 0.5723 | 0.8321 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 94.68 | 84.90 | 4031 | 7000 | 0.5758 | 0.8339 | MN20160318_Q02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 94.68 | 84.90 | 4978 | 7000 | 0.7111 | 0.8957 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 94.68 | 84.90 | 5013 | 7000 | 0.7161 | 0.8978 | MN20160318_Q02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 2.66 | 84.90 | 422 | 285 | 1.4769 | 1.4989 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 2.66 | 84.90 | 605 | 285 | 2.1173 | 2.0697 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 4.36 | 84.90 | 677 | 322 | 2.0988 | 1.9391 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 4.36 | 84.90 | 691 | 322 | 2.1422 | 1.9705 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 6.06 | 84.90 | 802 | 365 | 2.1945 | 1.9048 | MN20160318_Q02 | G10 |